Global Brain has invested in Persist AI Formulations Corp (Persist AI), an US-based AI/robotics startup that revolutionizes drug formulation processes, through its Shimadzu Future Innovation Fund L.P. (Shimadzu FIF). Drug formulation is a crucial process that transforms active pharmaceutical ingredients into patient-friendly forms—such as oral tablets, topical creams, or injectable solutions—so they can act safely and effectively within the patient’s body. However, this process currently relies heavily on the expertise of skilled engineers and remains labor- and time-intensive, leading to rising development costs and delays in development timelines. As a result, it often takes longer for promising new drugs to reach patients, potentially causing missed opportunities for timely treatment. To address these challenges, there is now a growing need for new approaches to drug formulation that can deliver innovative medicines to patients more quickly and reliably. Persist AI is developing a platform service that leverages its proprietary AI to rapidly generate optimal formulation recipes, and it utilizes its original robotics technology to automate formulation processes that have traditionally been performed manually. The service is designed to be accessible via the cloud, enabling remote usage. This is expected to help pharmaceutical companies and CDMOs (Contract Development and Manufacturing Organizations), who are both key customers and responsible for formulation, reduce development costs and shorten development timelines. Global Brain has decided to invest in Persist AI, recognizing the company’s technological innovation, the scalability of the formulation market, and the management team’s strong capabilities in both development and commercialization. Through this investment, Global Brain will contribute to the continued growth and success of Persist AI’s business in collaboration with Shimadzu Corporation.

About Persist AI

Location: California, US
CEO: Karthik Raman
Founded: June 2022
URL: ttps://www.persist-ai.com/

About Shimadzu FIF

Name: Shimadzu Future Innovation Fund L.P.
General Partner: Global Brain Corporation
Fund Size: JPY 5 billion
Fund Term: 10 years

About Global Brain

Location: Tokyo, Japan
Representative: Yasuhiko Yurimoto
Founded: January 1998
URL: https://globalbrains.com

Global Brain has invested in Persist AI Formulations Corp, an AI/robotics startup that revolutionizes drug formulation processes